suggested precision medicine merged article discuss proposed january 2016 part series genetics key components chromosome dna rna genome heredity mutation nucleotide variation outline index glossary history topics introduction history evolution molecular population genetics mendelian inheritance quantitative genetics molecular genetics research dna sequencing genetic engineering genomics template medical genetics branches genetics personalized medicine personalized medicine biology portal molecular cellular biology portal personalized medicine medical procedure separates patients groupswith medical decisions practices interventions andor products tailored individual patient based predicted response risk disease1 terms personalized medicine precision medicine stratified medicine p4 medicine interchangeably describe concept12 authors organisations expressions separately nuances2 tailoring treatment patients dates back time hippocrates3 term risen usage recent years growth diagnostic informatics approaches provide understanding molecular basis disease genomics clear evidence base stratify group related patients145 contents 1 development concept 2 background 2.1 basics 2.2 method 2.3 disease risk assessment 3 applications 3.1 diagnosis intervention 3.2 drug development usage 3.3 cancer genomics 4 challenges 4.1 regulatory oversight 4.2 intellectual property rights 4.3 reimbursement policies 4.4 patient privacy confidentiality 5 6 references development conceptedit personalised medicine diagnostic testing employed selecting optimal therapies based context patients genetic content molecular cellular analysis6 genetic information played major role aspects personalized medicine pharmacogenomics term coined context genetics broadened encompass sorts personalization measures6 backgroundedit basicsedit person unique variation human genome7 variation individuals effect health individuals health stems genetic variation behaviors influences environment89 biological variation manifests responsiveness drugs adhd medicine works ten preschoolers cancer drugs effective 25 patients depression drugs work 6 10 patientscitation needed modern advances personalized medicine rely technology confirms patients fundamental biology dna rna protein ultimately leads confirming disease personalized techniques genome sequencing reveal mutations dna influence diseases ranging cystic fibrosis cancer method called rna-seq show rna molecules involved specific diseases unlike dna levels rna change response environment sequencing rna provide broader understanding persons state health recent studies linked genetic differences individuals rna expression10 translation11 protein levels12 concepts personalized medicine applied transformative approaches health care personalized health care based dynamics systems biology predictive tools evaluate health risks design personalized health plans help patients mitigate risksprevent disease treat precision occurs concepts personalized health care receiving increasing acceptance veterans administration committing personalized proactive patient driven care veterans13 methodedit order physicians know mutation connected disease researchers study called genome-wide association study gwas gwas study look disease sequence genome patients disease look shared mutations genome mutations determined related disease gwas study diagnose disease future patients looking genome sequence find mutation gwas conducted 2005 studied patients age-related macular degeneration armd14 found mutations variation nucleotide called single nucleotide polymorphisms snps armd gwas studies successful identifying common genetic variations diseases early 2014 1,300 gwas studies completed15 disease risk assessmentedit multiple genes collectively influence likelihood developing common complex diseases8 personalized medicine predict persons risk disease based genes approach sequencing technology focus evaluation disease risk allowing physician initiate preventative treatment disease presents patient found dna mutation increases persons risk developing type 2 diabetes individual begin lifestyle lessen chances developing type 2 diabetes later life applicationsedit advances personalized medicine create unified treatment approach specific individual genome personalized medicine provide diagnoses earlier intervention efficient drug development therapies16 diagnosis interventionedit ability look patient individual basis allow accurate diagnosis specific treatment plan genotyping process obtaining individuals dna sequence biological assays17 detailed account individuals dna sequence genome compared reference genome human genome project assess existing genetic variations account diseases number private companies 23andme navigenics illumina created direct-to-consumer genome sequencing accessible public7 information individuals applied effectively treat individuals genetic make-up plays large role respond treatment knowing genetic content change type treatment receive aspect pharmacogenomics individuals genome provide informed tailored drug prescription18 drugs prescribed idea work application drugs number factors considered detailed account genetic information individual help prevent adverse events allow dosages create maximum efficacy drug prescriptions7 pharmacogenomic process discovery genetic variants predict adverse events specific drug termed toxgnostics19 addition specific treatment personalized medicine greatly aid advancements preventive care instance women genotyped mutations brca1 brca2 gene predisposed family history breast cancer ovarian cancer20 diseases mapped according mutations exist genome easier identified individual measures prevent disease developing mutations found genome details dna reduce impact delay onset diseases16 genetic content individual allow guided decisions determining source disease treating preventing progression extremely diseases alzheimers cancers thought linked mutations dna16 tool test efficacy safety drug specific targeted patient groupsub-group companion diagnostics technology assay developed drug made market helpful enhancing therapeutic treatment based individual21 companion diagnostics incorporated pharmacogenomic information related drug prescription label effort assist making optimal treatment decision patient21 drug development usageedit individuals genomic information significant process developing drugs await approval fda public detailed account individuals genetic make-up major asset deciding patient chosen inclusion exclusion final stages clinical trial16 able identify patients benefit clinical trial increase safety patients adverse outcomes caused product testing allow smaller faster trials lead lower costs22 addition drugs deemed ineffective larger population gain approval fda personal genomes qualify effectiveness need specific drug therapy needed small percentage population1623 today medicine common physicians trial error strategy find treatment therapy effective patient16 personalized medicine treatments specifically tailored individual give insight body respond drug drug work based genome7 personal genotype allow physicians detailed information guide decision treatment prescriptions cost-effective accurate16 quoted article pharmacogenomics promise personalized medicine therapy drug dose patient description personalized medicine affect future treatment24 instance tamoxifen drug commonly prescribed women er breast cancer 65 women initially taking developed resistance research people david flockhart discovered women mutation cyp2d6 gene gene encodes metabolizing enzyme able efficiently break tamoxifen making ineffective treatment cancer25 women genotyped specific mutations immediately women effective treatment therapy screening mutations carried high-throughput screening phenotypic screening drug discovery pharmaceutical companies utilizing technologies advance study personalized medicine amplify genetic research companies include alacris theranostics persomics flatiron health novartis oncodna foundation medicine alternative multi-target approaches traditional approach forward transfection library screening entail reverse transfection chemogenomics pharmacy compounding application personalized medicine necessarily utilizing genetic information customized production drug properties dose level ingredient selection route administration selected crafted individual patient accepted area personalized medicine contrast mass-produced unit doses fixed-dose combinations cancer genomicsedit recent decades cancer research discovered great deal genetic variety types cancer traditional pathology increasing awareness tumour heterogeneity genetic diversity single tumour prospects discoveries raise possibility finding drugs good results applied general population cases successful proportion cases genetic profiles cancer genomics oncogenomics application genomics personalized medicine cancer research treatment high-throughput sequencing methods characterize genes cancer understand disease pathology improve drug development oncogenomics promising branches genomics implications drug therapy examples include trastuzumab trade names herclon herceptin monoclonal antibody drug interferes her2neu receptor main treat breast cancers drug patients cancer tested over-expression her2neu receptor tissue-typing tests screen patients benefit herceptin treatment tissue tests immunohistochemistryihc fluorescence situ hybridizationfish26 her2 patients treated herceptin therapy trastuzumab27 tyrosine kinase inhibitors imatinib marketed gleevec developed treat chronic myeloid leukemia cml bcr-abl fusion gene product reciprocal translocation chromosome 9 chromosome 22 present 95 cases produces hyperactivated abl-driven protein signaling medications specifically inhibit ableson tyrosine kinase abl protein prime rational drug design based knowledge disease pathophysiology28 challengesedit personalized medicine practiced widely number challenges arise approaches intellectual property rights reimbursement policies patient privacy confidentiality regulatory oversight redefined restructured accommodate personalized medicine bring healthcare29 analysis acquired diagnostic data recent challenge personalized medicine adoption30 genetic data obtained next-generation sequencing requires computer-intensive data processing prior analysis31 future adequate tools required accelerate adoption personalized medicine fields medicine requires interdisciplinary cooperation experts specific fields research medicine clinical oncology biology software engineering regulatory oversightedit fda started take initiatives integrate personalized medicine regulatory policies developed report october 2013 entitled paving personalized medicine fdas role era medical product development outlined steps take integrate genetic biomarker information clinical drug development32 determined develop specific regulatory science standards research methods reference material tools order incorporate personalized medicine regulatory practices working genomic reference library regulatory agencies compare test validity sequencing platforms effort uphold reliability32 intellectual property rightsedit innovation medicine investment interest personalized medicine influenced intellectual property rights29 lot controversy regarding patent protection diagnostic tools genes biomarkers33 june 2013 supreme court ruled natural occurring genes patented synthetic dna edited artificially- created patented patent office reviewing number issues related patent laws personalized medicine confirmatory secondary genetic tests post initial diagnosis full immunity patent laws oppose patents argue patents dna sequences impediment ongoing research proponents point research exemption stress patents entice protect financial investments required commercial research development advancement services offered33 reimbursement policiesedit reimbursement policies redefined fit personalized medicine bring healthcare system factors considered level efficacy genetic tests general population cost-effectiveness relative benefits deal payment systems extremely rare conditions redefine insurance concept shared risk incorporate effect newer concept individual risk factors29 patient privacy confidentialityedit critical issue commercialization personalized medicine protection patients largest issues fear potential consequences patients predisposed genetic testing found non-responsive treatments includes psychological effects patients due genetic testing results family members directly consent issue considering genetic predispositions risks inheritable implications ethnic groups presence common allele considered29 2008 genetic information nondiscrimination act gina passed effort minimize fear patients participating genetic research ensuring genetic information misused employers insurers29 february 19 2015 fda issued press release titled fda permits marketing direct-to-consumer genetic carrier test bloom syndrome6 alsoedit chemogenomics drug discovery foundation medicine genetics next-generation sequencing pharmacogenetics pharmacogenomics phenotypic screening referencesedit stratified personalised p4 medicine direction placing patient centre healthcare health education technical report academy medical sciences 2015 retrieved 6 jan 2016 names concept concepts phg foundation retrieved 6 jan 2015 egnew thomas 1 mar 2009 suffering meaning healing challenges contemporary medicine annals family medicine 7 2 170175 doi101370afm943 retrieved 6 january 2016 case personalized medicine pdf personalized medicine coalition 2014 retrieved 6 jan 2016 smith richard 15 oct 2012 stratified personalised precision medicine british medical journal retrieved 6 january 2016 personalized medicine 101 personalized medicine coalition retrieved 26 april 2014 dudley karczewski 2014 exploring personal genomics oxford oxford university press personalized medicine 101 science personalized medicine coalition retrieved 26 april 2014 lu yf goldstein db angrist cavalleri 24 july 2014 personalized medicine human genetic diversity cold spring harbor perspectives medicine 4 9 a008581 doi101101cshperspecta008581 pmid25059740 alexis battle sara mostafavi xiaowei zhu james potash myrna weissman courtney mccormick christian haudenschild kenneth beckman jianxin shi rui mei alexander urban stephen montgomery douglas levinson daphne koller 2014 characterizing genetic basis transcriptome diversity rna-sequencing 922 individuals genome research 24 1 1424 doi101101gr155192113 pmid24092820 cs1 maint multiple names authors list link cenik cenik elif sarinay byeon gun candille sophie spacek damek araya carlos tang hua ricci emiliano snyder michael nov 2015 integrative analysis rna translation protein levels reveals distinct regulatory variation humans genome research 25 161021 doi101101gr193342115 pmid26297486 linfeng wu sophie candille yoonha choi dan xie lihua jiang jennifer li-pook-than hua tang michael snyder 2013 variation genetic control protein abundance humans nature 499 7456 7982 doi101038nature12223 pmc3789121 pmid23676674 snyderman personalized health care theory practice biotechnology 2012 7 haines jl apr 15 2005 complement factor variant increases risk age-related macular degeneration science 308 5720 41921 doi101126science1110359 pmid15761120 catalog published genome-wide association studies retrieved 28 june 2015 personalized medicine 101 promise personalized medicine coalition retrieved april 26 2014 research portfolio online reporting tools human genome project national institutes health nih retrieved april 28 2014 genetics home reference pharmacogenomics national institutes health nih retrieved april 28 2014 church kerr domingo rosmarin palles maskell tomlinson kerr 2014 toxgnostics unmet need cancer medicine nat rev cancer 6440-5 fact sheet brca1 brca2 cancer genetic testing national cancer institute nci retrieved april 28 2014 biomarker toolkit companion diagnostics pdf amgen archived original pdf august 1 2014 retrieved 2 2014 paving personalized medicine fdas role era medical product development pdf federal drug administration fda retrieved april 28 2014 path personalized medicine england journal medicine nejm 363 301304 july 22 2010 doi101056nejmp1006304 retrieved april 28 2014 mancinelli cronin sade 2000 pharmacogenomics promise personalized medicine aaps pharmsci 2 1 e4 pmc2750999 pmid11741220 cs1 maint multiple names authors list link breast cancer personal genomics era genomics bentham science retrieved april 28 2014 carney walter 2006 her2neu status important biomarker guiding personalized her2neu therapy pdf connection 9 2527 telli hunt carlson guardino 2007 trastuzumab-related cardiotoxicity calling question concept reversibility journal clinical oncology 25 23 35253533 doi101200jco2007110106 issn0732-183x pmid17687157 saglio morotti mattioli al december 2004 rational approaches design therapeutics targeting molecular markers case chronic myelogenous leukemia ann acad sci 1028 1 42331 bibcode2004nyasa1028423s doi101196annals1322050 pmid15650267 personalized medicine 101 challenges personalized medicine coalition retrieved april 26 2014 huser sincan cimino 2014 developing genomic knowledge bases databases support clinical management perspectives pharmacogenomics personalized medicine 7 27583 doi102147pgpms49904 pmc4175027 pmid25276091 analyze genomes motivation schapranow matthieu-p retrieved july 20 2014 paving personalized medicine fdas role era medical product development pdf food drug administration retrieved april 26 2014 intellectual property issues impacting future personalized medicine american intellectual property law association retrieved april 26 2014.dead link emerging technologies technology fields agriculture agricultural robot closed ecological systems cultured meat genetically modified food precision agriculture vertical farming architecture arcology building printing contour crafting d-shape domed city biomedical artificial uterus ampakine brain transplant cryonics cryoprotectant cryopreservation vitrification suspended animation de-extinction genetic engineering gene therapy head transplant isolated brain life extension strategies engineered negligible senescence nanomedicine nanosensors personalized medicine regenerative medicine stem-cell therapy tissue engineering robot-assisted surgery synthetic biology synthetic genomics virotherapy oncolytic virus tricorder genome sequencing displays generation fed flcd imod laser lpd oled olet qd-led sed tpd tdel tmos screenless bionic contact lens head-mounted display head-up display optical head-mounted display virtual retinal display autostereoscopy flexible display holographic display computer-generated holography multi-primary color display ultra hd volumetric display electronics electronic nose e-textiles flexible electronics molecular electronics nanoelectromechanical systems memristor spintronics thermal copper pillar bump energy production airborne wind turbine artificial photosynthesis biofuels carbon-neutral fuel concentrated solar power fusion power home fuel cell hydrogen economy methanol economy molten salt reactor nantenna photovoltaic pavement space-based solar power vortex engine storage beltway battery compressed air energy storage flywheel energy storage grid energy storage lithiumair battery molten salt battery nanowire battery research lithium-ion batteries siliconair battery thermal energy storage ultracapacitor smart grid wireless power communications ambient intelligence internet things artificial intelligence applications artificial intelligence progress artificial intelligence machine translation machine vision semantic web speech recognition atomtronics carbon nanotube field-effect transistor cybermethodology fourth-generation optical discs 3d optical data storage holographic data storage gpgpu memory cbram fram millipede mram nram pram racetrack memory rram sonos optical computing quantum computing quantum cryptography rfid chipless rfid software-defined radio three-dimensional integrated circuit manufacturing 3d printing claytronics molecular assembler utility fog materials science aerogel amorphous metal artificial muscle conductive polymer femtotechnology fullerene graphene high-temperature superconductivity high-temperature superfluidity linear acetylenic carbon metamaterials metamaterial cloaking metal foam multi-function structures nanotechnology carbon nanotubes molecular nanotechnology nanomaterials picotechnology programmable matter quantum dots silicene superalloy synthetic diamond military antimatter weapon caseless ammunition directed-energy weapon laser maser particle-beam weapon sonic weapon coilgun railgun plasma weapon pure fusion weapon stealth technology vortex ring gun neuroscience artificial brain blue brain project braincomputer interface electroencephalography mind uploading brain-reading neuroinformatics neuroprosthetics bionic eye brain implant exocortex retinal implant robotics domotics nanorobotics powered exoskeleton self-reconfiguring modular robot swarm robotics uncrewed vehicle space science launch fusion rocket non-rocket spacelaunch mass driver orbital ring space elevator space fountain space tether reusable launch system propulsion beam-powered propulsion ion thruster laser propulsion plasma propulsion engine helicon thruster vasimr project orion nuclear pulse propulsion solar sail interstellar travel propellant depot transport aerial adaptive compliant wing aeroscraft backpack helicopter delivery drone flying car high-altitude platform jet pack pulse detonation engine scramjet spaceplane skylon supersonic transport land airless tire tweel alternative fuel vehicle hydrogen vehicle driverless car ground effect train maglev train personal rapid transit vactrain et3 global alliance hyperloop vehicular communication systems pipeline pneumatic transport automated vacuum collection foodtubes anti-gravity cloak invisibility digital scent technology force field plasma window immersive virtual reality virtusphere magnetic refrigeration phased-array optics quantum technology quantum teleportation topics collingridge dilemma differential technological development ephemeralization exploratory engineering fictional technology proactionary principle technological change technological unemployment technological convergence technological evolution technological paradigm technology forecasting accelerating change moores law technological singularity technology scouting technology readiness level technology roadmap transhumanism category list 